Arvinas (ARVN) EBITDA Margin Growth (5y) (2022 - 2026)
Arvinas (ARVN) EBITDA Margin Growth (5y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Arvinas | 519.68 Mn | -95.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34,921.00 |
| Dec 31, 2025 | -16,531.00 |
| Sep 30, 2025 | 31,338.00 |
| Jun 30, 2025 | 14,158.00 |
| Mar 31, 2025 | 41,303.00 |
| Dec 31, 2024 | 36,743.00 |
| Sep 30, 2024 | -7,721.00 |
| Jun 30, 2024 | 39,533.00 |
| Mar 31, 2024 | 6,449.00 |
| Dec 31, 2023 | 87,605.00 |
| Sep 30, 2023 | 20,294.00 |
| Jun 30, 2023 | 11,364.00 |
| Mar 31, 2023 | -16,562.00 |
| Dec 31, 2022 | 631.00 |
| Sep 30, 2022 | 19,050.00 |
| Jun 30, 2022 | 20,828.00 |
| Mar 31, 2022 | 16,080.00 |